Clinical Trials Browser

Unknown × INDUSTRY × Lymphoma, Non-Hodgkin × Clear all

NCT06206902 2024-02-23

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT03650933 2024-02-20

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Phase 3 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05150405 2024-01-23

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05487651 2023-05-18

ANCHOR2

Phase 1 Unknown

LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Phase 1 Unknown

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT04502394 2022-08-04

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05206071 2022-01-25

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT00003337 2021-08-16

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04296461 2021-01-22

Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT04666168 2020-12-14

A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT04447547 2020-09-29

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT04497688 2020-08-04

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT03778619 2020-07-28

MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT03790891 2020-03-13

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin

NCT04237428 2020-01-23

CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT03720496 2019-12-09

Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT03497533 2019-09-06

Trident19-H

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT03910842 2019-09-06

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT03528421 2018-07-16

Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT03456466 2018-03-07

Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT03154775 2017-05-16

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT02856685 2016-08-22

A Study of Mitoxantrone Hydrochloride Liposome Infusion

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT01983761 2013-11-18

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Phase 1/2 Unknown

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

NCT01570049 2012-08-02

Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma

Phase 3 Unknown

Lymphoma, Non-Hodgkin

NCT00109356 2007-05-07

Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00078598 2005-11-09

A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

Phase 3 Unknown

Lymphoma, Non-Hodgkin, Recurrence

NCT00022906 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT00022932 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00022958 2005-06-24

Expanded Access Study of Iodine-131 Anti-B1 Antibody

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT00036426 2005-06-24

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Lymphoma, Non-Hodgkin

NCT00081783 2005-06-24

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

Phase 2 Unknown

Lymphoma, Non-Hodgkin